Journals / Fırat Tıp Dergisi / 2016 / Cilt: 21 - Sayı: 1

Serum ADMA, MDA, Vitamin E and Homocysteine Levels in Vitiligo Patients

Vitiligolu Hastalarda Serum ADMA, MDA, Vitamin E ve Homosistein Düzeyleri

Pages
29–34
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: According to our results, we conclude that reduced vitamin E levels and increased levels of homocysteine, MDA and ADMA may constitute a distinctive feature in vitiligo.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Vitiligo is an acquired depigmenting disorder caused by the destruction of melanocytes.
📊
Key Findings & Data:Material and Method: This randomized case control study was performed on 50 subjects: 30 patients suffering from vitiligo and 20 healthy controls.
💡
Conclusion & Impact:Conclusion: According to our results, we conclude that reduced vitamin E levels and increased levels of homocysteine, MDA and ADMA may constitute a distinctive feature in vitiligo.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Vitiligo is an acquired depigmenting disorder caused by the destruction of melanocytes. The exact etiopathogenesis and mechanisms of vitiligo are not fully understood. Several groups have shown the involvement of oxidative stress in the pathophysiology of vitiligo. The aim of this study was to study for any association of vitiligo with serum homocysteine, asymmetric dimethylarginine (ADMA), vitamin A, vitamin E and malondialdehyde levels (MDA). Material and Method: This randomized case control study was performed on 50 subjects: 30 patients suffering from vitiligo and 20 healthy controls. Venous blood was collected from each subject to estimate the levels of vitamin A, E, MDA, ADMA and homocysteine. The serum levels of these parameters in both groups were measured using High Performance Liquid Chromatography (HPLC).Results: The levels of serum vitamin E were significantly decreased in vitiligo patients (p=0.004), while serum MDA, homocysteine and ADMA levels were significantly increased (p<0.0001), and the levels of vitamin A were almost the same in patients as in the control subjects (p>0.05). Conclusion: According to our results, we conclude that reduced vitamin E levels and increased levels of homocysteine, MDA and ADMA may constitute a distinctive feature in vitiligo.

Özet

Amaç: Vitiligo, melanosit yıkımı ileseyreden kazanılmış bir depigmentasyon hastalığıdır. Vitiligonun gerçek etyopatogenezisi ve mekanizması tam olarak anlaşılamamıştır. Çeşitli gruplar, vitiligo patofizyolojisinde oksidatif stres katılımını göstermiştir. Bu çalışmanın amacı vitiligonun serum homosistein, asimetrik dimetilarginin (ADMA), vitamin A, vitamin E ve malondialdehit (MDA) düzeyleri ile ilişkisini araştırmaktır. Gereç ve Yöntem: Bu randomize vaka kontrol çalışması 30 vitiligo hastası ve 20 sağlıklı kontrol olmak üzere 50 birey üzerinde gerçekleştirilmiştir. Her bireyden serum kan örnekleri vitamin A, vitamin E, MDA, ADMA ve homosistein düzeylerini belirlemek üzere toplanmıştır. Bu parametrelerin düzeyleri her iki grupta da High Performance Liquid Chromatography-Yüksek Performanslı Sıvı Kromatografi (HPLC) cihazı kullanarak çalışılmıştır. Bulgular: Serum vitamin E düzeyleri vitiligolu hastalarda istatistiksel olarak anlamlı düşük iken (p=0.004), serum MDA, homosistein ve ADMA düzeyleri anlamlı olarak artmıştı (p 0.05). Sonuç: Biz vitamin E düzeylerinin azalmasının ve homosistein, MDA ve ADMA düzeylerinin artmasının vitiligoda belirgin bir özellik teşkil ettiği sonucuna vardık.

🔖

Cite This Article

KAMANA, D., DEMİR, B. (2016). Serum ADMA, MDA, Vitamin E and Homocysteine Levels in Vitiligo Patients. Fırat Tıp Dergisi, Cilt: 21 - Sayı: 1, 29–34. https://ajindex.com/articles/198284

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Mosher DB. Hypomelanoses and hypermelanoses. In:Freedberg IM, Eisen AZ, WolV K, Austen KF, Goldsmith LA, Katz SI et al (eds) Fitzpatrick's dermatology in general medicine. McGraw-Hill, New York, 1999; 945-1018
  2. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991; 97: 1081-1085
  3. Knight JA. Diseases related to oxygen-derived free radicals. Ann Clin Lab 1995; 25: 111-121
  4. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037
  5. Gong L, Pitari GM, Schulz A, Waldman SA. Nitricoxide signaling: systems integration of oxygen balancein defense of cell integrity. Curr Opin Hematol 2004; 11: 7-14
  6. Monteiro HP, Silva EF, Stern A. Nitric oxide: apotential inducer of adhesion-related apoptosis-anoikis.Nitric Oxide 2004; 10: 1-10
  7. Brune B, von Knethen A, Sandau KB. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ 1999; 6: 969-975
  8. Liu L, Stamler JS. NO: an inhibitor of cell death. Cell Death Differ 1999: 6: 937-942. 9. van den Wijngaard RM, Wankowicz-Kalinska A, Pals S, Weening J, Das PK. Autoimmune melanocytedestruction in vitiligo. Lab Invest 2001; 81: 1061-1067
  9. Wankowicz-Kalinska A, van den Wijngaard RM, Tigges BJ et al. Immunopolarization of CD4+ and CD8+ T cells to type-1- like is associated withmelanocyte loss in human vitiligo. Lab Invest 2003; 83: 683-695
  10. Das PK, van den Wijngaard RM, Wankowicz- Kalinska A, Le Poole IC. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol 2001; 22: 130-136
  11. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996; 148: 1219-1228
  12. Iuga AO, Qureshi AA, Lerner EA. Nitric oxide is toxic to melanocytes in vitro. Pigment Cell Res 2004; 17: 302-306
  13. Lentz SR, Rodionow RN, Dayol S. Hyperhomocysteinemia, endothelial dysfunction and cardiovascular risk: the potential role of ADMA. Atherosclerosis Suppl 2003; 4: 61-65
  14. Boger RH. Association of asymmetric dimethylarginine and endothelial dysfunction Clin Chem Lab Med 2003; 41: 1467-72
  15. Silverberg JI, Silverberg NB. Serum homocysteine as a biomarker of vitiligo vulgaris severity: A pilot study. J Am Acad Dermatol 2011; 64: 445-447
  16. Hann SK. Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo. In: Hann SK, Nordlund JJ (